---
document_datetime: 2025-11-20 15:14:39
document_pages: 3
document_pathfilename: www.ema.europa.eu/en/documents/procedural-steps-after/izamby-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf
document_name: izamby-epar-procedural-steps-taken-scientific-information-after-authorisation_en.pdf
version: success
processing_time: 1.6794617
conversion_datetime: 2025-12-28 18:03:13.344307
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.66.0
  docling-core: 2.57.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
## Izamby

Procedural steps taken and scientific information after the authorisation*

*Due to the Agency`s update of its procedure management systems, an additional document, reflecting the historical lifecycle may be available in the 'Assessment history' section. For the complete product lifecycle procedures, you may need to also refer to EPAR - Procedural steps taken and scientific information after authorisation (archive) .

| Application number   | Scope                                  | Opinion/ Notification 1 issued on   | Commission Decision Issued 2 / amended on   | Product Information affected 3   | Summary   |
|----------------------|----------------------------------------|-------------------------------------|---------------------------------------------|----------------------------------|-----------|
| Variation type IB /  | This was an application for a group of | 20/11/2025                          |                                             | SmPC and PL                      |           |

<!-- image -->

<!-- image -->

<div style=\"page-break-after: always\"></div>

| EMA/VR/0000307311   | variations.   |
|---------------------|---------------|

<div style=\"page-break-after: always\"></div>

|                                       | parent product Prolia. In addition, editorial changes have been performed in section 4.2 and 5.2 to align the PI to parent product, polysorbate number (E432) has been included alignment with QRD 10.4 has been performed. Moreover, some language specific changes were applied in BG, CS, DA, DE, EL, ES, ET, FI, FR, HR, HU, IT, LT, LV, MT, NL, NO, PT, RO, SK, PL, SL, SV annexes to align the related language to the parent product counterpart.   |            |     |    |
|---------------------------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|------------|-----|----|
| Variation type IB / EMA/VR/0000300531 | This was an application for a variation following a worksharing procedure according to Article 20 of Commission Regulation (EC) No 1234/2008. B.II. FINISHED PRODUCT - B.II.z To update Module 3.2.A.1 for a biotech medicinal product - Accepted                                                                                                                                                                                                          | 06/11/2025 | N/A |    |
| Variation type IB / EMA/VR/0000301808 | B.II.e) Container closure system - B.II.e.z Other variation - Accepted                                                                                                                                                                                                                                                                                                                                                                                     | 10/10/2025 | N/A |    |
| Article 61(3) / EMA/N/0000288023      | - Notification acc. Article 61(3) - Accepted Update of the package leaflet with revised contact details of local representatives.                                                                                                                                                                                                                                                                                                                          | 29/07/2025 |     | PL |